Global Endowment Management’s Bristol-Myers Squibb BMY Stock Holding History

Global Endowment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,980	Closed	-$300K	–	128
2020 Q3	$300K	Hold	4,980	–	–	0.02%	107
2020 Q2	$293K	Hold	4,980	–	–	0.02%	93
2020 Q1	$278K	Hold	4,980	–	–	0.03%	82
2019 Q4	$320K	Buy	+4,980	New	+$285K	0.02%	87
2019 Q3	–	Sell	-36,700	Closed	-$1.67M	–	100
2019 Q2	$1.67M	Buy	+36,700	New	+$1.71M	0.16%	55
2018 Q3	–	Sell	-117,000	Closed	-$6.47M	–	221
2018 Q2	$6.47M	Buy	+117,000	New	+$6.32M	0.85%	23
2017 Q3	–	Sell	-59,100	Closed	-$3.29M	–	241
2017 Q2	$3.29M	Buy	+59,100	New	+$3.22M	0.45%	40
2017 Q1	–	Sell	-48,580	Closed	-$2.84M	–	247
2016 Q4	$2.84M	Sell	48,580 -17,300	-26%	-$946K	0.44%	36
2016 Q3	$3.55M	Buy	+65,880	New	+$4.23M	0.59%	38

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Global Endowment Management's BMY Position: Q4 2020 in Review

Global Endowment Management sold out of Bristol-Myers Squibb (BMY) in Q4 2020, closing a stake of 4,980 shares — an estimated $300K sold.

Global Endowment Management first reported a position in BMY in Q3 2016 and held it in 9 quarters. The position peaked at $6.47M in Q2 2018. 2,359 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

Global Endowment Management reported no remaining Bristol-Myers Squibb position as of Q4 2020 after selling out during the quarter.
Global Endowment Management sold 4,980 Bristol-Myers Squibb shares in Q4 2020, an estimated $300K.
Global Endowment Management first reported a position in Bristol-Myers Squibb in Q3 2016 and held it in 9 quarters.
Global Endowment Management's Bristol-Myers Squibb position peaked at $6.47M in Q2 2018.
2,359 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Global Endowment Management's 13F filing for Q4 2020, filed 11 Feb 2021.